News | August 03, 2022
Shivalik Rasayan Ltd inks marketing agreement with China Chinopharma
The CSC shall hold Market Authorisation (MA) to sell SRL's BUSALFAN, API exclusively in China territory.
The CSC shall hold Market Authorisation (MA) to sell SRL's BUSALFAN, API exclusively in China territory.
This includes USD 100 million to advance R&D of its neglected tropical disease program, focusing on novel drug candidates for four diseases.
The unit is an oral manufacturing facility at Jedcherla, Hyderabad
Technology Development Board supports commercialisation of Metal Injection Molding of implants
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
Nureca Ltd has reported financial results for the period ended June 30, 2021.
The company posted net profit of Rs.594.6 crores for the period ended June 30, 2020.
Novo Medi Sciences aims to reach millions nationwide and provide NEXIPOX PLUS vaccination against chickenpox to thousands of underprivileged girl children
On segmental performance, API revenues were largely stable at Rs. 454.3 crore for Q3 FY26, down 1% YoY
Operating profit fell 1% in Danish kroner to DKK 127.7 billion but rose 6% at constant exchange rates
Subscribe To Our Newsletter & Stay Updated
